Cargando…

A Gene Panel, Including LRP12, Is Frequently Hypermethylated in Major Types of B-Cell Lymphoma

Epigenetic modifications and DNA methylation in particular, have been recognized as important mechanisms to alter gene expression in malignant cells. Here, we identified candidate genes which were upregulated after an epigenetic treatment of B-cell lymphoma cell lines (Burkitt's lymphoma, BL; F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bethge, Nicole, Honne, Hilde, Andresen, Kim, Hilden, Vera, Trøen, Gunhild, Liestøl, Knut, Holte, Harald, Delabie, Jan, Lind, Guro E., Smeland, Erlend B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165585/ https://www.ncbi.nlm.nih.gov/pubmed/25226156 http://dx.doi.org/10.1371/journal.pone.0104249

Ejemplares similares

Colorectal cancer DNA methylation marker panel validated with high performance in Non-Hodgkin lymphoma
por: Bethge, Nicole, et al.
Publicado: (2014)

Identification of Highly Methylated Genes across Various Types of B-Cell Non-Hodgkin Lymphoma
por: Bethge, Nicole, et al.
Publicado: (2013)

Experimental factors affecting the robustness of DNA methylation analysis
por: Pharo, Heidi D., et al.
Publicado: (2016)

CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma
por: Trøen, Gunhild, et al.
Publicado: (2013)

Novel target genes and a valid biomarker panel identified for cholangiocarcinoma
por: Andresen, Kim, et al.
Publicado: (2012)

Comprehensive genome-wide transcription factor analysis reveals that a combination of high affinity and low affinity DNA binding is needed for human gene regulation
por: Wang, Junbai, et al.
Publicado: (2015)

Integrating whole genome sequencing, methylation, gene expression, topological associated domain information in regulatory mutation prediction: A study of follicular lymphoma
por: Farooq, Amna, et al.
Publicado: (2022)

Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years
por: Barzenje, Dlawer Abdulla, et al.
Publicado: (2015)

High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells
por: Blystad, AK, et al.
Publicado: (2001)

Role of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma
por: Huse, Kanutte, et al.
Publicado: (2012)

Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study
por: Wang, Junbai, et al.
Publicado: (2002)

A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL
por: Isaksen, Kathrine T., et al.
Publicado: (2021)

Transformation of B cell lymphoma to histiocytic sarcoma: somatic mutations of PAX-5 gene with loss of expression cannot explain transdifferentiation
por: Bassarova, Assia, et al.
Publicado: (2009)

The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy
por: Isaksen, Kathrine T., et al.
Publicado: (2023)

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
por: Stokke, T, et al.
Publicado: (2001)

Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma
por: Lázcoz, Paula, et al.
Publicado: (2006)

Transgelin gene is frequently downregulated by promoter DNA hypermethylation in breast cancer
por: Sayar, Nilufer, et al.
Publicado: (2015)

Frequent hypermethylation of orphan CpG islands with enhancer activity in cancer
por: Bae, Min Gyun, et al.
Publicado: (2016)

Association of frequent hypermethylation with high grade histological subtype in lung adenocarcinoma
por: Ito, Yuki, et al.
Publicado: (2023)

Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma
por: Andresen, Kim, et al.
Publicado: (2015)

TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK
por: Bakkebø, Maren, et al.
Publicado: (2010)

A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
por: Lind, Guro E, et al.
Publicado: (2004)

The loss of NKX3.1 expression in testicular – and prostate – cancers is not caused by promoter hypermethylation
por: Lind, Guro E, et al.
Publicado: (2005)

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
por: Marie Vedeld, Hege, et al.
Publicado: (2015)

Hypermethylated MAL gene – a silent marker of early colon tumorigenesis
por: Lind, Guro E, et al.
Publicado: (2008)

Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence
por: Truong, M, et al.
Publicado: (2012)

Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
por: Juhlin, C. Christofer, et al.
Publicado: (2010)

PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance
por: Zhang, Cheng, et al.
Publicado: (2016)

Induction of the BRAF(V600E) Mutation in Thyroid Cells Leads to Frequent Hypermethylation
por: Yi, Jin Wook, et al.
Publicado: (2022)

Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile
por: Vedeld, Hege Marie, et al.
Publicado: (2021)

MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
por: Håvik, Annette Bentsen, et al.
Publicado: (2012)

Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer
por: Katargin, Alexey N, et al.
Publicado: (2009)

ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma
por: Götze, Silke, et al.
Publicado: (2009)

The apoptosis associated tyrosine kinase gene is frequently hypermethylated in human cancer and is regulated by epigenetic mechanisms
por: Haag, Tanja, et al.
Publicado: (2014)

Claudin11 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin, but Uncommon in Nevus Cell Nevi
por: Walesch, Sara K., et al.
Publicado: (2015)

ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer
por: Tang, Gao-Yan, et al.
Publicado: (2019)

Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score ≥ 7
por: Miyauchi, Toshiya, et al.
Publicado: (2021)

TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
por: Wang, Shumin, et al.
Publicado: (2010)

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma
por: Tong, Joanna H, et al.
Publicado: (2010)

Mutations in Isocitrate Dehydrogenase 1 and 2 Occur Frequently in Intrahepatic Cholangiocarcinomas and Share Hypermethylation Targets with Glioblastomas
por: Wang, Pu, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lrg2f9c7h09js9tcuaa2v9hu5t